Mizuho Securities USA’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Mizuho Securities USA's GILD Position: Q2 2026 in Review
Mizuho Securities USA increased its Gilead Sciences (GILD) stake by 30% in Q2 2026, buying an estimated $2.92M and bringing the position to 97,201 shares worth $12.3M. The position accounts for 0.2% of the portfolio, ranked #81.
Mizuho Securities USA first reported a position in GILD in Q2 2013 and has held it in 19 quarters since. The position peaked at $13.9M in Q4 2013. 2,277 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Mizuho Securities USA held 97,201 shares of Gilead Sciences worth $12.3M as of Q2 2026.
- Mizuho Securities USA bought 22,196 Gilead Sciences shares in Q2 2026, an estimated $2.92M.
- Gilead Sciences made up 0.2% of Mizuho Securities USA's portfolio in Q2 2026, its #81 holding.
- Mizuho Securities USA first reported a position in Gilead Sciences in Q2 2013 and has held it in 19 quarters since.
- Mizuho Securities USA's Gilead Sciences position peaked at $13.9M in Q4 2013.
- 2,277 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Mizuho Securities USA's 13F filing for Q2 2026, filed 24 Jul 2026.